Inactive Instrument

Anteris Technologies Ltd Stock price Other OTC

Equities

AMEUF

AU0000088841

Medical Equipment, Supplies & Distribution

Sales 2024 * 5.6M 3.65M Sales 2025 * 5.6M 3.65M Capitalization 425M 277M
Net income 2024 * -76M -49.57M Net income 2025 * -82M -53.48M EV / Sales 2024 * 70.9 x
Net cash position 2024 * 28M 18.26M Net cash position 2025 * 32M 20.87M EV / Sales 2025 * 70.2 x
P/E ratio 2024 *
-6.52 x
P/E ratio 2025 *
-6.91 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 87.6%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 56 14-10-09
Director of Finance/CFO - 18-11-22
Chief Tech/Sci/R&D Officer - 21-09-05
Members of the board TitleAgeSince
Chairman 72 14-10-09
Director/Board Member - 18-10-30
Chief Executive Officer 56 14-10-09
More insiders
Anteris Technologies Ltd is an Australia-based company that is engaged in the research and development (R&D) of its structural heart products. The Company is engaged in the manufacture and sale of ADAPT regenerative tissue products globally. It is focused on developing biomimetic transcatheter aortic valve replacement (TAVR) for the treatment of aortic stenosis. ADAPT is the Company's patented anti-calcification tissue technology. Its DurAVR THV is a three dimensional (3D) single piece valve and is a biomimetic design that replicates the normal blood flow of a healthy human aortic valve. The Company also provides ComASUR Delivery System, a balloon expandable system with the ability to rotate valves for predictable alignment with the heart's native commissure.
More about the company
  1. Stock
  2. Equities
  3. Stock Anteris Technologies Ltd
  4. Stock Anteris Technologies Ltd - Other OTC